Jing Bao - Concepedia

Author

Jing Bao

Peking University ORCID

Also Known As

J Bao, J. BAO, J. Bao, Jasmine Yimeng Bao, Jiachen Bao, Jianbo Bao, Jing Bao, Jing Q Bao, Jing Q. Bao, Junyin Bao

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Peking University Johns Hopkins University Eli Lilly (United States)Johns Hopkins Medicine Henry M. Jackson Foundation

About

Jing Bao is an author at Peking University specializing in medicine, hospital medicine, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	278
2	Public Health	2	2	132
3	Health Sciences	1	1	12
4	Emergency Medicine	1	1	74
5	Epidemiology	1	1	58

Jing Bao

Publications

921

Citations

H-Index

Page 1

	Year	Citations
Utility of Oatp1a/1b-Knockout and OATP1B1/3-Humanized Mice in the Study of OATP-Mediated Pharmacokinetics and Tissue Distribution: Case Studies with Pravastatin, Atorvastatin, Simvastatin, and Carboxydichlorofluorescein J. William Higgins, Jing Bao, Alice Ke, Drug Metabolism and Disposition	2013	92
Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats Using Loperamide, Paclitaxel, Sulfasalazine, and Carboxydichlorofluorescein Pharmacokinetics Maciej J. Zamek‐Gliszczynski, David W. Bedwell, Jing Bao, Drug Metabolism and Disposition	2012	91
S100A4+ Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts Yanan Li, Jing Bao, Yangyang Bian, Frontiers in Immunology	2018	85
The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder Zhu Feng Yue, Fay Y. Womer, Haixia Leng, Frontiers in Psychiatry	2019	84
Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series Dkm Ip, Qiang Liao, Peng Wu, BMJ	2013	82
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial Mina C. Hosseinipour, Gregory P. Bisson, Sachiko Miyahara, The Lancet Pulmonary TuberculosisAntiretroviral TherapyHiv/aids CounsellingTreatment And PreventionTuberculosis Prevention	2016	79
Acute Myocardial Injury at Hospital Admission Is Associated With All-Cause Mortality in COVID-19 Wentao Ni, Xiuwen Yang, Jie Liu, Journal of the American College of Cardiology All-cause MortalityCardiovascular DiseaseHospital AdmissionMyocardial InfarctionCovid-19 Pandemic	2020	74
Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China Tao Li, Lei Lu, Weishuo Zhang, Archives of Gerontology and Geriatrics Hospitalized Older PatientsMedicineCovid-19 PandemicClinical EpidemiologyCovid-19 Epidemiology	2020	58
Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin Kelly E. Dooley, Anne F. Luetkemeyer, Jeong‐Gun Park, Antimicrobial Agents and Chemotherapy PharmacotherapyAntimicrobial ChemotherapyAntiviral DrugPre-clinical PharmacologyDrug Resistance	2014	51
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults Gregory P. Bisson, Ritesh Ramchandani, Sachiko Miyahara, AIDS	2017	47

Page 1